{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-001230","form_type":"8-K","ticker":"CCRN","cik":"0001141103","company_name":"CROSS COUNTRY HEALTHCARE INC","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.234775+00:00","generated_at":"2026-06-12T11:38:56.031668+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cross Country Healthcare Q2 revenue down 28% YoY; guides Q3 lower","bullets":["Q2 revenue $540.7M (-28% YoY, -13% sequential); diluted EPS $0.60 vs $1.40 YoY.","Adjusted EBITDA $44.4M (8.2% margin) vs $83.5M (11.1%) YoY; adjusted EPS $0.69 vs $1.40.","Physician Staffing revenue +105% YoY to $45.3M; Nurse & Allied -32% to $495.4M.","Repaid $73.9M term loan; repurchased 200K shares for $4.7M.","Q3 guidance: revenue $440-450M; adjusted EPS $0.35-0.45; indicates continued decline."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-001230","json":"https://secwatch.observer/filing/0001157523-23-001230.json","markdown":"https://secwatch.observer/filing/0001157523-23-001230.md","text":"https://secwatch.observer/filing/0001157523-23-001230.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323001230/0001157523-23-001230-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323001230/a53496471.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T11:38:56.031668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"28212496613c03447382b97c6af95bcdbad080ae","claim":"CROSS COUNTRY HEALTHCARE INC reported the quarter ended June 30, 2023 results: revenue $540.7 million, net income $21.3 million, EPS $0.60. Guidance initiated.","evidence_excerpt":"clients to optimize their workforce, and to further improve our profitability as we continue to penetrate the vendor neutral space.” Second quarter consolidated revenue was $540.7 million, a decrease of 28% year-over-year and 13% sequentially. Consolidated gross profit margin was 22.8%, up 20 basis points year-over-year and 40 basis points sequentially. Net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323001230/0001157523-23-001230-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$540.7 million"},{"label":"Net income","value":"$21.3 million"},{"label":"EPS","value":"$0.60"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"9e0afd17e7c09307bfd8bd770bfa1d07595ea3d1","claim":"CROSS COUNTRY HEALTHCARE INC reported the six months ended June 30, 2023 results: revenue $1.2 billion, net income $50.8 million, EPS $1.41. Guidance initiated.","evidence_excerpt":"For the six months ended June 30, 2023, consolidated revenue was $1.2 billion, a decrease of 25% year-over-year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323001230/0001157523-23-001230-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the six months ended June 30, 2023"},{"label":"Revenue","value":"$1.2 billion"},{"label":"Net income","value":"$50.8 million"},{"label":"EPS","value":"$1.41"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}